MyDx's Award Winning Handheld Analyzer Moves to Market

SEATTLE, WA - The reliability of cannabis testing has become a challenge in an industry that GreenWave Advisors believes could reach $35 billion by 2020. With tens of thousands of products recalled for illegal pesticide use, cannabis consumers face a lot of uncertainty when buying products off dispensary shelves. Separate studies have shown that THC and CBD concentrations are regularly mislabeled and could create problems for medical and recreational users alike. There is no quick, easy, or affordable way for consumers to test cannabis safety and composition.

MyDx Inc. (OTCQB: MYDX) has spent the last three years and close to $7.6 million in capital researching, developing, and bringing to market a solution for consumers to quickly, easily, and affordably determine the safety and composition of what they eat, drink and inhale. The solution is MyDx, a handheld chemical analyzer. The company is positioned to scale and expand its applications this...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.